• 1
    Enstrom JE, Kanim LE, Klein MA. Vitamin C intake and mortality among a sample of the United States population. Epidemiology 1992; 3 : 194202.
  • 2
    Armstrong BK, Mann JI, Adelstein M, Eskin F. Commodity consumption and ischemic heart disease mortality, with special reference to dietary practices. J Chron Dis 1975; 28 : 45569.
  • 3
    Acheson RM, Williams DRR. Does consumption of fruit and vegetables protect against stroke? Lancet 1983; 1 : 11913.
  • 4
    Bulpitt CJ. Vitamin C and blood pressure. J Hypertens 1990; 8 : 10715.
  • 5
    Verlangieri AJ, Kapeghian JC, El-Dean S, Bush M. Fruit and vegetable consumption and cardiovascular mortality. Med Hypotheses 1985; 16 : 715.
  • 6
    Key TJA, Thorogood M, Appleby PN, Burr ML. Dietary habits and mortality in 11 000 vegetarians and health conscious people: results of a 17 year follow up. BMJ 1996; 13 : 7759.
  • 7
    Bazzano LA, He J, Ogden LG et al. Legume consumption and risk of coronary heart disease in US men and women. Arch Intern Med 2001; 161 : 25738.
  • 8
    Gillman MW, Cupples LA, Gagnon D et al. Protective effect of fruits and vegetables on development of stroke in men. JAMA 1995; 273 : 11137.
  • 9
    Strandhagen E, Hansson PO, Bosaeus I, Isaksson B, Eriksson H. High fruit intake may reduce mortality among middle-aged and elderly men. The study of men born in 1913. Eur J Clin Nutr 2000; 54 : 33741.
  • 10
    Hensrud DD, Heimburger DC, Chen J, Parpia B. Antioxidant status, erythrocyte fatty acids, and mortality from cardiovascular diseases. Eur J Clin Nutr 1994; 48 : 45564.
  • 11
    Law MR, Morris JK. By how much does fruit and vegetable consumption reduce the risk of ischaemic heart disease. Eur J Clin Nutr 1998; 52 : 54956.
  • 12
    Fraser GE. Diet and coronary heart disease: beyond dietary fats and low-density-lipoprotein cholesterol. Am J Clin Nutr 1994; 59 (Suppl.): 111723.
  • 13
    Fraser GE, Lindstedt KD, Beeson L. Effect of risk factors values on lifetime risk of and age at first coronary event. Am J Epidemiol 1995; 142 : 74658.
  • 14
    Hu FB, Stamper MJ, Manson JAE et al. Frequent nut consumption and risk of coronary heart disease in women: prospective cohort study. BMJ 1998; 317 : 13415.
  • 15
    Criqui M, Ringel BL. Does diet or alcohol explain the French paradox? Lancet 1994; 344 : 171923.
  • 16
    Imai K, Nakachi K. Cross-sectional study of effects of drinking green tea on cardiovascular and liver diseases. BMJ 1995; 310 : 6936.
  • 17
    Hertog MGL, Feskens EJM, Hollman PCH, Katan MB, Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993; 342 : 100711.
  • 18
    Bellizzi MC, Franklin MF, Duthie GG, James WPT. Vitamin E and coronary heart disease: the European paradox. Eur J Clin Nutr 1994; 48 : 82231.
  • 19
    Gey KF. Vitamin E and other essential antioxidants regarding coronary heart disease: risk assessment studies. Epidemiological basis of the antioxidant hypothesis of cardiovascular disease. In: Packer L, Fuchs J, eds. Vitamin E in Health and Disease. New York: Dekker, 1993; 589–633.
  • 20
    Gey KF, Puska P, Jordan P, Moser UK. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 1991; 53 : 326S34S.
  • 21
    Howard AN, Williams NR, Palmer CR et al. Do hydroxy-carotenoids prevent coronary heart disease? A comparison between Belfast and Toulouse. Int J Vitam Nutr Res 1996; 66 : 1138.
  • 22
    Kristenson M, Ziedén B, Kucinskiene Z et al. Antioxidant state and mortality from coronary heart disease in Lithuanian and Swedish men: concomitant cross-sectional study of men aged 50. BMJ 1997; 314 : 62938.
  • 23
    Bobak M, Brunner E, Miller NJ, Skodova Z, Marmot M. Could antioxidants play a role in high rates of coronary heart disease in the Czech Republic? Eur J Clin Nutr 1998; 52 : 6326.
  • 24
    Bonithon-Kopp C, Coudray C, Berr C et al. Combined effects of lipid peroxidation and antioxidant status on carotid atherosclerosis in a population aged 59–71 years: the EVA study. Am J Clin Nutr 1997; 65 : 1217.
  • 25
    Kritchevsky SB, Shimakawa T, Tell GS et al. Dietary antioxidants and carotid artery wall thickness. The Atherosclerosis Risk in Communities Study. Circulation 1995; 92 : 214250.
  • 26
    De Waart FG, Moser U, Kok FJ. Vitamin E supplementation in elderly lowers the oxidation rate of linoleic acid in LDL. Atherosclerosis 1997; 133 : 25563.
  • 27
    Bolton-Smith C, Woodward M, Tunstall-Pedoe H, The Scottish Heart Health Study. Dietary intake by food frequency questionnaire and odds ratios for coronary heart disease risk. II. The antioxidant vitamins and fibre. Eur J Clin Nutr 1992; 46 : 859.
  • 28
    Singh RB, Ghosh S, Niaz MA, Singh R, Beegum R et al. Dietary intake, plasma levels of antioxidant vitamins, and oxidative stress in relation to coronary artery disease in elderly subjects. Am J Cardiol 1996; 76 : 12338.
  • 29
    Khaw K-T, Bingham S, Welch A et al. Relation between plasma ascorbic acid and mortality in men and women in EPIC-Norfolk prospective study: a prospective population study. Lancet 2001; 357 : 65763.
  • 30
    Anonymous. Att förebygga sjukdom med antioxidanter [Prevention of diseases by antioxidants]. SBU-rapport no. 135. Stockholm: SBU, 1997.
  • 31
    Review Manager Version 4.1. Oxford: The Cochrane Collaboration and Update Software Ltd., 2000.
  • 32
    Mashima R, Witting PK, Stocker R. Oxidants and antioxidants in atherosclerosis. Curr Opin Lipidol 2001; 12 : 4118.
  • 33
    Steinberg D. Oxidative modification of LDL and atherogenesis. Circulation 1993; 95 : 106271.
  • 34
    Nenseter MS, Volden V, Berg T et al. No effect of β-carotene supplementation on the susceptibility of low density lipoprotein to in vitro oxidation among hypercholesteroaemic, postmenopausal women. J Clin Lab Invest 1995; 55 : 47785.
  • 35
    Fuller CJ, Huet BA, Jialal I. Effects of increasing doses of alpha-tocopherol in providing protection of low-density lipoprotein from oxidation. Am J Cardiol 1998; 81 : 2313.
  • 36
    Singh RB, Singh NK, Rastogi SS, Mani UV, Niaz MA. Effects of diet and lifestyle changes on atherosclerotic risk factors after 24 weeks in the Indian Diet Heart Study. Am J Cardiol 1993; 71 : 12838.
  • 37
    Bierenbaum ML, Reichstein RP, Bhagavan HN, Watkins TR. Relationship between serum lipid peroxidation products in hypercholesterolemic subjects and vitamin E status. Biochem Int 1992; 28 : 5766.
  • 38
    Jialal I, Fuller CJ. Oxidized LDL and antioxidants. Clin Cardiol 1993; 16 (Suppl. I):169.
  • 39
    Jialal I, Grundy SM. Effect of combined supplementation with α-tocopherol, ascorbate, and β-carotene on low-density lipoprotein oxidation. Circulation 1993; 88 : 27806.
  • 40
    Mosca L, Rubenfire M, Mandel C et al. Antioxidant nutrient supplementation reduces the susceptibility of low density lipoprotein to oxidation in patients with coronary artery disease. J Am Coll Cardiol 1997; 30 : 3929.
  • 41
    Kaikkonen J, Nyyssonen K, Tomasi A et al. Antioxidative efficacy of parallel and combined supplementation with coenzyme Q and d-alpha-tocopherol in mildly hypercholesterolemic subjects: a randomized placebo-controlled clinical study. Free Radicals Res 2000; 33 : 32940.
  • 42
    Thomas SR, Neuzil J, Stocker R. Cosupplementation with coenzyme Q prevents the prooxidant effect of alpha-tocopherol and increases the resistance of LDL to transition metal-dependent oxidation initiation. Arterioscler Thromb Vasc Biol 1996; 16 : 68796.
  • 43
    Church JP, Judd JT, Young CW, Kelsay JL, Kim WW. Relationship among dietary constituents and specific serum clinical components of subjects eating self-selected diets. Am J Clin Nutr 1984; 40 : 133844.
  • 44
    Simon JA. Vitamin C and cardiovascular disease: a review. J Am Coll Nutr 1992; 11 : 10725.
  • 45
    Maxwell SRJ. Can anti-oxidants prevent ischaemic heart disease? J Clin Pharmacol Ther 1993; 18 : 8595.
  • 46
    Bostom AG, Hume AL, Eaton CB, Laurino JP, Yanek LR. The effect of high-dose ascorbate supplementation on plasma lipoprotein(a) levels in patients with premature coronary heart disease. Pharmacotherapy 1995; 15 : 45864.
  • 47
    Sciarrone SE, Strahan MT, Beilin LJ, Burke V, Rogers P, Rouse IR. Ambulatory blood pressure and heart rate responses to vegetarian meals. J Hypertens 1993; 11 : 27785.
  • 48
    Rouse IL, Beilin LJ, Armstrong BK, Vandongen R. Vegetarian diet, blood pressure and cardiovascular risk. Aust NZ Med 1984; 14 : 43943.
  • 49
    Appel LJ, Moore TJ, Obarzanek E et al. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med 1997; 336 : 111724.
  • 50
    Moran JP, Cohen L, Greene JM et al. Plasma ascorbic acid concentrations relate inversely to blood pressure in human subjects. Am J Clin Nutr 1993; 57 : 2137.
  • 51
    Duffy SJ, Gokce N, Holbrook M et al. Treatment of hypertension with ascorbic acid. Lancet 1999; 354 : 20489.
  • 52
    Salonen JT, Salonen R, Ihanainen M et al. Blood pressure, dietary fats, and antioxidants. Am J Clin Nutr 1988; 48 : 122632.
  • 53
    Nilsson TK, Sundell IB, Hellsten G, Hallmans G. Reduced plasminogen activator inhibitor activity in high consumers of fruits, vegetables and root vegetables. J Intern Med 1990; 227 : 26771.
  • 54
    Koh KK, Blum A, Hathaway L et al. Vascular effects of estrogen and vitamin E therapies in postmenopausal women. Circulation 1999; 100 : 18517.
  • 55
    Stampfer MJ, Jakubowski JA, Faigel D, Vaillancourt R, Deykin D. Vitamin E supplementation effect on human platelet function, arachidonic acid metabolism, and plasma prostacyclin levels. Am J Clin Nutr 1988; 47 : 7006.
  • 56
    Lake AM, Stuart MJ, Oski FA. Vitamin E deficiency and enhanced platelet function: reversal following E supplementation. J Pediatr 1977; 90 : 7225.
  • 57
    Steiner M. Vitamin E: more than an antioxidant. Clin Cardiol 1993: 16 (Suppl. I): 1168.
  • 58
    Salonen JT, Salonen R, Seppänen K et al. Effects of antioxidant supplementation on platelet function: a randomized pair-matched, placebo-controlled, double-blind trial in men with low antioxidant status. Am J Clin Nutr 1991; 53 : 12229.
  • 59
    Freedman JE, Farhat JH, Loscalzo J, Keaney JF. α-Tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation 1996; 94 : 243440.
  • 60
    Gokce N, Frei B. Basic research in antioxidant inhibition of steps in atherogenesis. J Cardiovasc Risk 1996; 3 : 3527.
  • 61
    Iribarren C, Folsom AR, Jacobs DR, Gross MD, Belcher JD, Eckfeldt JH. Association of serum vitamin levels, LDL susceptibility to oxidation, and autoantibodies against MDA-LDL with carotid atherosclerosis. Arterioscler Thromb Vasc Biol 1997; 17 : 11717.
  • 62
    Reinisch N, Kiechl S, Mayr C et al. Association of high plasma antioxidant capacity with new lesion formation in carotid atherosclerosis: a prospective study. Eur J Clin Invest 1998; 28 : 78792.
  • 63
    Motoyama T, Kawano H, Kugiyama K et al. Vitamin E administration improves impairment of endothelium-dependent vasodilation in patients with coronary spastic angina. J Am Coll Cardiol 1998; 32 : 16729.
  • 64
    Taddei S, Virdis A, Ghiadoni L, Magagna A, Salvetti A. Vitamin C improves endothelium-dependent vasodilation by restoring nitric oxide activity in essential hypertension. Circulation 1998; 97 : 22229.
  • 65
    Kugiyama K, Motoyama T, Hirashima O et al. Vitamin C attenuates abnormal vasomotor reactivity in spasm coronary arteries in patients with coronary spastic angina. J Am Coll Cardiol 1998; 32 : 1039.
  • 66
    Guyrech D, Martin B, Schilling J, Bumbaer B, Gutzwiller F. Schützen Antioxidantien vor Myokardinfarkt? Schweiz Rundsch Med Prax 1994; 83 : 7327.
  • 67
    Hense HW, Stender M, Bors W, Keil U. Lack of an association between serum vitamin E and myocardial infarction in a population with high vitamin E levels. Atherosclerosis 1993; 103 : 218.
  • 68
    Sharpe PC, Mulholland C, Trinick T. Ascorbate and malondialdehyde in stroke patients. Ir J Med Sci 1994; 163 : 48891.
  • 69
    Gupta SK, Singh U, Sharma P. Serum tocopherols and lipids in patients with coronary artery disease. Indian Heart J 1998; 50 : 2924.
  • 70
    Kardinaal AFM, Kok FJ, Ringstad J et al. Antioxidants in adipose tissue and risk of myocardial infarction. The EURAMIC Study. Lancet 1993; 342 : 137984.
  • 71
    Kohlmeier L, Kark JD, Gomez-Garcia E et al. Lycopene and myocardial infarction risk in the EURAMIC study. Am J Epidemiol 1997; 146 : 61826.
  • 72
    Meyer F, Bairati I, Dagenais G. Lower ischemic heart disease incidence and mortality among vitamin supplement. Can J Cardiol 1996; 12 : 9304.
  • 73
    Klipstein-Grobusch K, Geleijnse JM, Breeijen den JH, Hofman A, Grobbee DE, Witterman JCM. Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam study. Am J Clin Nutr 1999; 69 : 2616.
  • 74
    Manson JA, Stampfer MJ, Willett WC et al. A prospective study of antioxidant vitamins and incidence of coronary heart disease in women. Circulation 1991; 84 : II546.
  • 75
    Rimm EB, Stampfer MJ, Ascherio A, Giovanucci E, Colditz GA et al. Vitamin E consumption and the risk of coronary disease in men. N Engl J Med 1993; 328 : 14506.
  • 76
    Knekt P, Reunanen A, Järvinen R, Seppänen R, Heliövaara M, Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994; 1390 : 11809.
  • 77
    Pandey DK, Shekelle R, Selwyn BJ, Tangney C, Stamler J. Dietary vitamin C and β-carotene and risk of death in middle-aged men. Am J Epidemiol 1995; 142 : 126978.
  • 78
    Keli SO, Hertog MGL, Feskens EJM, Kromhout D. Dietary flavonoids, antioxidant vitamins and incidence of stroke. Arch Intern Med 1996; 156 : 63742.
  • 79
    Sahyoun NR, Jacques PF, Russell RM. Carotenoids, vitamins C and E, and mortality in an elderly population. Am J Epidemiol 1996; 144 : 50111.
  • 80
    Kromhout D, Bloemberg BPM, Feskens EJM, Hertog MGL, Menotti A, Blackburn H. Alcohol, fish, fibre and antioxidant vitamins intake do not explain population differences in coronary heart disease mortality. Int J Epidemiol 1996; 25 : 7539.
  • 81
    Stampfer MJ, Hennekens CH, Manson JAE, Colditz GA, Rosner B, Willett WC. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993; 328 : 14449.
  • 82
    Kushi LH, Folsom AR, Prineas R, Mink P, Wu Y, Bostick RM. Dietary antioxidants and death from coronary heart disease in postmenopausal women. N Engl J Med 1996; 334 : 115662.
  • 83
    Losonczy KG, Harris TB, Havlik RJ. Vitamin E and vitamin C supplement use and risk of all cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. Am J Clin Nutr 1996; 64 : 1906.
  • 84
    Hill RJ, Davies PS. The validity of self-reported energy intake as determined using the doubly labelled water technique. Br J Nutr 2001; 85 : 41530.
  • 85
    The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group. The effect of vitamin E and beta-carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330 : 102935.
  • 86
    Omenn GS, Goodman E, Thornquist MD et al. Effects of a combination of beta-carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334 : 11505.
  • 87
    Collaborative Group of the Primary Prevention Project (PPP). Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Lancet 2001; 357 : 8995.
  • 88
    Hennekens CH, Buring JE, Manson JE et al. Lack of effect on long-term supplementation with beta-carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334 : 11459.
  • 89
    Blot WJ, Li JY, Taylor PR et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993; 84 : 148391.
  • 90
    Leppala JM, Virtamo J, Fogelholm R et al. Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers. Arterioscler Thromb Vasc Biol 2000; 20 : 2305.
  • 91
    Ferns GAA, Konneh M, Änggård EE. Vitamin E: the evidence for an antiatherogenic role. Artery 1993; 20 : 6194.
  • 92
    Jandak J, Steiner M, Richardson PD. α-Tocopherol, an effective inhibitor of platelet adhesion. Blood 1989; 73 : 1419.
  • 93
    De Lorgeril M, Salen P, Martin JL, Monjaud I, Delaye J, Mamelle N. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 1999; 16 : 77985.
  • 94
    Davey PJ, Schulz M, Gliksman M, Dobson M, Aristides M, Stephens NG. Cost-effectiveness of vitamin E therapy in the treatment of patients with angiographically proven coronary narrowing (CHAOS trial). Am J Cardiol 1998; 82 : 4147.
  • 95
    Hodis HN, Mack WJ, LaBree L et al. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA 1995; 23 : 184954.
  • 96
    Kleijnen J, Mackerras D. Vitamin E for intermittent claudication (Cochrane Review). In: The Cochrane Library, Issue 1, 2002. Oxford: Update Software.
  • 97
    Leng GC, Lee AJ, Fowkes GR et al. Randomized controlled trial of antioxidants in intermittent claudication. Vascular Med 1997; 2 : 27985.
  • 98
    Stephens NG, Parson A, Schofield PM, Kelly F, Cheeseman K, Mitchinson MJ. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347 : 7816.
  • 99
    Ness A, Egger M, Davey Smith G. Role of antioxidant vitamins in prevention of diseases. Meta-analysis seems to exclude benefit of vitamin C supplementation. BMJ 1999; 319 : 577577.
  • 100
    Jha P, Flather M, Lonn E, Farkouh M, Yusuf S. The antioxidant vitamins and cardiovascular disease. Ann Intern Med 1995; 123 : 86072.
  • 101
    Parthasarathy S, Khan-Merchant N, Penumetcha M, Khan BV, Santanam N. Did the antioxidant trials fail to validate the oxidation hypothesis? Curr Atherosclerosis Rep 2001; 3 : 3928.
  • 102
    Schwartz JL. The dual roles of nutrients as antioxidants and prooxidants: their effects on tumor cell growth. J Nutr 1996; 126 (Suppl. 4): 1221S7S.
  • 103
    Young AJ, Lowe GM. Antioxidant and prooxidant properties of carotenoids. Arch Biochem Biophys 2001; 385 : 207.
  • 104
    Gerster H. High-dose vitamin C: a risk for persons with high iron stores? Int J Vitam Nutr Res 1999; 69 : 6782.
  • 105
    Houston DK, Johnson MA, Daniel TD, Poon LW. Health and dietary characteristics of supplement users in an elderly population. Int J Vit Nutr Res 1997; 67 : 18391.
  • 106
    Levy Y, Bartha P, Ben-Amotz A et al. Plasma antioxidants and lipid peroxidation in acute myocardial infarction and thrombosis. J Am Coll Nutr 1998; 17 : 33741.
  • 107
    Byers T, Bowman B. Vitamin E supplements and coronary heart disease. Nutr Rev 1993; 51 : 3336.
  • 108
    Barer D, Leibowitz R, Ebrahim S, Pengally D, Neale R. Vitamin C status and other nutritional indices in patients with stroke and other acute illnesses: a case–control study. J Clin Epidemiol 1989; 42 : 62531.
  • 109
    Riemersma RA, Wood DA, Macintyre CCA, Elton RA, Gey KF, Oliver MF. Risk of angina pectoris and plasma concentrations of vitamins A, C and E and carotene. Lancet 1991; 337 : 15.
  • 110
    Eichholzer M, Staehelin HB, Gey KF. Inverse correlation between essential antioxidants in plasma and subsequent risk to develop cancer, ischemic heart disease and stroke respectively: 12 year follow-up of the Prospective Basel Study. In: Emerit I, Chance B, eds. Free Radicals and Aging. Basel: Birkhäuser, 1992.
  • 111
    Tzonou A, Kalandidi A, Trichopoulou A et al. Diet and coronary heart disease: a case–control study in Athens, Greece. Epidemiology 1993; 4 : 5116.
  • 112
    Duthie GG, Beattie JA, Arthur JR, Franklin M, Morrice PC, James WP. Blood antioxidants and indices of lipid peroxidation in subjects with angina pectoris. Nutrition 1994; 10 : 3136.
  • 113
    Street DA, Comstock GW, Salkeld RM, Shüep W, Klag MJ. Serum antioxidants and myocardial infarction. Are low levels of carotenoids and alpha-tocopherol risk factors for myocardial infarction? Circulation 1994; 90 : 115461.
  • 114
    Kim SY, Lee-Kim YC, Kim MK et al. Serum levels of antioxidant vitamins in relation to coronary artery disease: a case–control study of Koreans. Biomed Environ Sci 1996; 9 : 22935.
  • 115
    Öhrvall M, Sundlöf G, Vessby B. Gamma, but not alpha, tocopherol levels in serum are reduced in coronary heart disease patients. J Intern Med 1996; 239 : 1117.
  • 116
    Rejon FR, Pena GM, Manglano L, Martinez VS, Galiana JR. Niveles plasmaticos de vitaminas A y E y riesgo de infarto agudo de miocardio. Rev Clin Esp 1997; 197 : 4116.
  • 117
    Kostner K, Hornykewycz S, Yang P et al. Is oxidative stress causally linked to unstable angina pectoris? A study in 100 CAD patients and matched controls. Cardiovasc Res 1997; 36 : 3306.
  • 118
    Tavani A, Negri E, D'Avanzo B, La Vecchia C. Beta-carotene intake and risk of nonfatal acute myocardial infarction in women. Eur J Epidemiol 1997; 13 : 6317.
  • 119
    Marzatico F, Gaetani P, Tartara F, Bertirelli L, Feletti F, Adinolfi D. Antioxidant status and alfa-1-antiproteinase activity in subarachnoid hemorrhage patients. Life Sci 1998; 63 : 8216.
  • 120
    Kardinaal AF, Aro A, Kark JD et al. Association between beta-carotene and acute myocardial infarction depends on polyunsaturated fatty acid status. Arterioscler Thromb Vasc Biol 1995; 15 : 72632.
  • 121
    Evans RW, Shaten BJ, Day BW, Kuller LH. Prospective association between lipid soluble antioxidants and coronary heart disease in men. Am J Epidemiol 1998; 147 : 1806.
  • 122
    Kontush A, Spranger T, Reich A, Kaum K, Beisiegel U. Lipophilic antioxidants in blood plasma as markers of atherosclerosis: the role of α-carotene and β-tocopherol. Atherosclerosis 1999; 144 : 11722.DOI: 10.1016/s0021-9150(99)00044-1
  • 123
    Gey KF, Stähelin HB, Eichholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel Prospective Study. Clin Invest 1993; 71 : 36.
  • 124
    Fehily AM, Yarnell JWG, Sweetnam PM, Elwood PC. Diet and incident ischaemic heart disease: the Caerphilly study. Br J Nutr 1993; 69 : 30314.
  • 125
    Morris DL, Kritchevski SB, Davis CE. Serum carotenoids and coronary heart disease. JAMA 1994; 272 : 143941.
  • 126
    Daviglus ML, Orencia AJ, Dyer AR et al. Dietary vitamin C, beta-carotene and 30-year risk of stroke: results from the Western Electric Study. Neuroepidemiology 1997; 16 : 6977.
  • 127
    Gale CR, Martyn CN, Winters PD, Cooper C. Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. BMJ 1995; 310 : 15636.
  • 128
    Gale CR, Martyn CN, Cooper C. Cognitive impairment and mortality in a cohort of elderly people. BMJ 1996; 312 : 60811.
  • 129
    Greenberg ER, Baron JA, Karagas MR et al. Mortality associated with low plasma concentration of beta-carotene and the effect of oral supplementation. JAMA 1996; 275 : 699703.
  • 130
    Nyyssönen K, Parviainen MT, Salonen R, Tuomilehto J, Salonen JT. Vitamin E deficiency and risk of myocardial infarction: prospective population study of men from eastern Finland. BMJ 1997; 314 : 6348.
  • 131
    Ross RK, Yuan J-M, Henderson BE, Park J, Gao Y-T, Yu MC. Prospective evaluation of dietary and other predictors of fatal stroke in Shanghai, China. Circulation 1997; 96 : 505.
  • 132
    Mark SD, Wang W, Fraumeni JF et al. Do nutritional supplements lower the risk of stroke or hypertension? Epidemiol 1998; 9 : 915.
  • 133
    Virtamo J, Rapola JM, Ripatti S et al. Effects of vitamin E and beta-carotene on the incidence of primary nonfatal myocardial infection and fatal coronary heart disease. Arch Intern Med 1998; 158 : 66875.
  • 134
    De Klerk NH, Musk AW, Ambrosini GL et al. Vitamin A and cancer prevention II: comparison of the effects of retinol and β-carotene. Int J Cancer 1998; 75 : 3627.DOI: 10.1002/(sici)1097-0215(19980130)75:3<362::aid-ijc6>;2-0
  • 135
    Salonen JT, Nyysönen K, Salonen R et al. Antioxidant supplementation in atherosclerosis prevention (ASAP) study: a randomized trial of the effect of vitamins E and C on 3-year progression of carotid atherosclerosis. J Intern Med 2000; 248 : 37786.DOI: 10.1046/j.1365-2796.2000.00752.x
  • 136
    Steiner M, Glantz M, Lekos A. Vitamin E plus aspirin compared with aspirin alone in patients with transient ischaemic attacks. Am J Clin Nutr 1995; 62 (Suppl.): 1381S4S.
  • 137
    Rapola JM, Virtamo J, Ripatti S et al. Randomised trial of alfa-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 1997; 349 : 171520.
  • 138
    Anonymous. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 1999; 354 : 44755.
  • 139
    Hennekens CH, Gaziano JM. Antioxidants and heart disease: epidemiology and clinical evidence. Clin Cardiol 1993; 16 : 105.
  • 140
    DeMaio SJ, King SB III, Lembo NJ et al. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA). J Am Coll Nutr 1992; 11 : 6873.
  • 141
    Rapola JM, Virtamo J, Ripatti S et al. Effects of alpha-tocopherol and beta-carotene supplements on symptoms, progression, and prognosis of angina pectoris. Heart 1998; 79 : 4548.
  • 142
    Tardif J-C, Coté G, Lespérance J et al. Propucol and multivitamins in the prevention of restenosis after coronary angioplasty. N Engl J Med 1997; 337 : 36572.
  • 143
    The Heart Outcomes Prevention Evaluation Study Investigators. Vitamin E supplementation and cardiovascular events in high-risk patients. N Engl J Med 2000; 342 : 15460.
  • 144
    Lonn EM, Yusuf S, Dzavik V et al. Effects of ramipril and vitamin E on atherosclerosis. Circulation 2001; 103 : 91925.
  • 145
    Brown BG, Zhao X-Q, Chait A et al. Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease. N Engl J Med 2001; 345 : 158392.
  • 146
    Anonymous. MRC/BHF Heart Protection Study of cholesterol-lowering therapy and of antioxidant vitamins supplementation in a wide range of patients at increased risk of coronary heart disease death: early safety and efficacy experience. Eur Heart J 1999; 20 : 72541.
  • 147
    Anonymous. Results from the Heart Protection Study (HPS), available at website, 2001.
  • 148
    Buring JE, Hennekens CH. Randomized trials of primary prevention of cardiovascular disease in women. An investigator's view. Ann Epidemiol 1994; 4 : 1114.
  • 149
    Hoffman RM, Garewal HS. Antioxidants and the prevention of coronary heart disease. Arch Intern Med 1995; 155 : 2416.
  • 150
    Manson JE, Gaziano JM, Spelsberg A et al. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women. Rationale, design, and methods. The WACS Research Group. Ann Epidemiol 1995; 5 : 3335.
  • 151
    Hercberg S, Galan P, Preziosi P et al. Background and rationale behind the SU.VI.MAX study, a prevention trial using nutritional doses of a combination of antioxidant vitamins and minerals to reduce cardiovascular diseases and cancers. Int J Vit Nutr Res 1998; 68 : 320.
  • 152
    Hercberg S, Preziosi P, Briancon S et al. A primary prevention trial using nutritional doses of antioxidant vitamins and minerals in cardiovascular diseases and cancers in a general population: the SU.VI.MAX study-design, methods, and participant characteristics Control Clin Trials 1998; 19: 33651.
  • 153
    Christen WG, Gaziano JM, Hennekens CH. Design of Physicians' Health Study II – a randomized trial of beta-carotene, vitamins E and C, and multivitamins in prevention of cancer, cardiovascular disease, and eye disease, a review of completed trials. Ann Epidemiol 2000; 10 : 12534.